About the Guests:
Kevin has spent his career researching and developing various DNA sequencing technologies in both the research and clinical industries. Additionally, Kevin has had a parallel interest in driving the tools used for personalized medicine into the world of cannabis medicine. Kevin believes the intersection of personalized medicine, genomics, blockchains and cannabis is one of the most exciting growth opportunities in our lifetime.
Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and held the position of Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLID sequencing technology. Integral to the SOLID R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 journal covers from Science Translational Medicine to Nature.
Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. Kevin oversaw the growth and research of APG until it was sold to Applied BioSystems. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until 2005 where it was acquired by Beckman Coulter. From 1996 to 2000 Kevin managed the Research and Development for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoys boating, skiing, and gardening.
Naomi Brockwell is a film and television producer, and host of the show “Bitcoin, Blockchain, and the Technologies of our Future”. She is a producer for Stossel, a producer for the TV series HardFork, and formerly produced for Fox Business Network and Fox News Channel.
Naomi is the co-founder of The Soho Forum, on the Advisory Council at the Mannkal Economic Education Foundation, and in 2017 was awarded Uber’s “Young Libertarian of the Year” at the Friedman Conference.
She has produced numerous award-winning feature films, including the 2015 feature documentary Bitcoin: The End of Money as We Know It (Best International Documentary, Anthem Film Festival; Winner of Special Jury Prize, Amsterdam Film Festival), Audition (Best documentary, Lone Star Film Festival) and the Lionsgate thriller, Subconscious.
Check out her daily videos at Youtube.com/NaomiBrockwellTV
If you like this content, please send a tip with BTC to: 1444meJi7YjgQGNg3U8Z6qYZFA5cgz4Gmj
Friends and Sponsors of the Show: